Tamotsu Sagawa, Masahiro Hirakawa, Hiroyuki Nagashima, Koshi Fujikawa. Cancer of Unknown Primary in Transition: From Empirical Chemotherapy to Immunotherapy and Molecularly Guided Treatment. // Asia-Pacific Journal of Clinical Oncology. – 2026. – DOI: 10.1111/ajco.70220. – URL: https://onlinelibrary.wiley.com/doi/10.1111/ajco.70220?af=R
Tamotsu Sagawa, Masahiro Hirakawa, Hiroyuki Nagashima, & Koshi Fujikawa (2026). Cancer of Unknown Primary in Transition: From Empirical Chemotherapy to Immunotherapy and Molecularly Guided Treatment. Asia-Pacific Journal of Clinical Oncology. https://doi.org/10.1111/ajco.70220
Tamotsu Sagawa, et al. “Cancer of Unknown Primary in Transition: From Empirical Chemotherapy to Immunotherapy and Molecularly Guided Treatment.” Asia-Pacific Journal of Clinical Oncology, 2026. doi:10.1111/ajco.70220.
@article{Sagawa2026,
title = {Cancer of Unknown Primary in Transition: From Empirical Chemotherapy to Immunotherapy and Molecularly Guided Treatment},
author = {Sagawa, Tamotsu and Hirakawa, Masahiro and Nagashima, Hiroyuki and Fujikawa, Koshi},
journal = {Asia-Pacific Journal of Clinical Oncology},
year = {2026},
doi = {10.1111/ajco.70220},
url = {https://onlinelibrary.wiley.com/doi/10.1111/ajco.70220?af=R}
}